Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Articles /     
 
Effect of four different antiarrhythmic protocols in boxers with VPC
Ventricular premature complexes (VPC) are diagnosed in a number of boxers with or without clinical signs of syncopal episodes. There are different treatment protocols recommended at the moment. Which of the four most commonly used is the best?

The effect of 4 antiarrhythmic treatment protocols on number of ventricular premature complexes (VPC), severity of arrhythmia, heart rate (HR), and number of syncopal episodes in 49 Boxers with ventricular tachyarrhythmias was investigated in a randomized controlled clinical trial.
Dogs with > 500 VPC/24 h via 24-hour ambulatory ECG (AECG) were treated with atenolol (n = 11), procainamide (11), sotalol (16), or mexiletine and atenolol (11) for 21 to 28 days. Results of pre- and posttreatment AECG were compared with regard to number of VPC/24 h; maximum, mean, and minimum HR; severity of arrhythmia; and occurrence of syncope.
Significant differences between pre- and posttreatment number of VPC, severity of arrhythmia, HR variables, or occurrence of syncope were not observed in dogs treated with atenolol or procainamide. Significant reductions in number of VPC, severity of arrythmia, and maximum and mean HR were observed in dogs treated with mexiletine-atenolol or sotalol; occurrence of syncope was not significantly different between these 2 treatment groups.

Treatment with sotalol or mexiletine-atenolol was well tolerated and efficacious. Treatment with procainamide or atenolol was not effective.

Source: Meurs KM, et al (2002): Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. In: J Am Vet Med Assoc 2002 Aug 15;221(4):522-7




Tell a friend   |   Print version   |   Send this article

ARTICLES

Pharmacokinetics of quinocetone in ducks after two routes of administrationmembers
Quinocetone (QCT), an antimicrobial growth promoter, is widely used in food-producing animals. However, information about pharmacokinetics (PK) of QCT in ducks still remains unavailable up to now. In this study, QCT and its major metabolites (1-desoxyquinocetone, di-desoxyquinocetone and 3-methyl-quinoxaline-2-carboxylic) in ducks were studied using a simple and sensitive UHPLC-MS/MS assay.

  • Novel antibiotic treatment of zebrafish mycobacteriosismembers
  • Canine mammary tumours as model for hereditary breast cancer susceptibility genes in humansmembers
  • Treatment of corneal ulceration in stranded California sea lions members
  • Effects of substrates and stress on placental metabolismmembers
  • Vaccine regimens against caecal Salmonella Typhimurium colonisation in laying hensmembers
  • Presumptive keratoglobus in a raptormembers
  • Monitored, controlled long-term anaesthesia in broiler chickenmembers
  • Pharmacokinetics of cefovecin in alpacasmembers
  • Use and effect of hand antiseptics in veterinary practicemembers
  • Two dogs with cold agglutinin activitymembers
  • Mechanical ventilation and blood gases and blood pressure in rattlesnakesmembers
  • Infectious haemolytic anemia in an orphaned juvenile female platypus members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved